These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1471864)

  • 21. Lateralized differences in iodine-123-IBZM uptake in the basal ganglia in asymmetric Parkinson's disease.
    Knable MB; Jones DW; Coppola R; Hyde TM; Lee KS; Gorey J; Weinberger DR
    J Nucl Med; 1995 Jul; 36(7):1216-25. PubMed ID: 7790947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. D2 receptor imaging with iodine-123-iodobenzamide brain SPECT in infants with hypoxic-ischemic brain injury.
    Kapucu LO; Koç E; Gücüyener K; Zenciroğlu A; Atalay Y; Unlü M; van Royen E
    J Nucl Med; 1998 Oct; 39(10):1703-7. PubMed ID: 9776272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine D2 receptor imaging with iodine-123-iodobenzamide SPECT in idiopathic rotational torticollis.
    Hierholzer J; Cordes M; Schelosky L; Richter W; Keske U; Venz S; Semmler W; Poewe W; Felix R
    J Nucl Med; 1994 Dec; 35(12):1921-7. PubMed ID: 7989970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initial clinical experiences with dopamine D2 receptor imaging by means of 2'-iodospiperone and single-photon emission computed tomography.
    Yonekura Y; Saji H; Iwasaki Y; Tsuchida T; Fukuyama H; Shimatsu A; Iida Y; Magata Y; Konishi J; Yokoyama A
    Ann Nucl Med; 1995 Aug; 9(3):131-6. PubMed ID: 8534585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The determination of cerebral dopamine (D2) receptor density by using 123I-IBZM-SPECT in Parkinson disease patients].
    Hierholzer J; Cordes M; Schelosky L; Barzen G; Poewe W; Henkes H; Keske U; Horowski R; Felix R
    Rofo; 1992 Oct; 157(4):390-8. PubMed ID: 1391843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine D2 receptor imaging with SPECT: studies in different neuropsychiatric disorders.
    Brücke T; Podreka I; Angelberger P; Wenger S; Topitz A; Küfferle B; Müller C; Deecke L
    J Cereb Blood Flow Metab; 1991 Mar; 11(2):220-8. PubMed ID: 1671782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Striatal D2 receptor binding in sleep bruxism: a controlled study with iodine-123-iodobenzamide and single-photon-emission computed tomography.
    Lobbezoo F; Soucy JP; Montplaisir JY; Lavigne GJ
    J Dent Res; 1996 Oct; 75(10):1804-10. PubMed ID: 8955676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Striatal dopaminergic D(2) receptor density measured by [(123)I]iodobenzamide SPECT in the prediction of treatment outcome of alcohol-dependent patients.
    Guardia J; Catafau AM; Batlle F; Martín JC; Segura L; Gonzalvo B; Prat G; Carrió I; Casas M
    Am J Psychiatry; 2000 Jan; 157(1):127-9. PubMed ID: 10618027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantification of IBZM dopamine receptor SPET in de novo Parkinson patients before and during therapy.
    Hertel A; Weppner M; Baas H; Schreiner M; Maul FD; Baum RP; Fischer PA; Hör G
    Nucl Med Commun; 1997 Sep; 18(9):811-22. PubMed ID: 9352546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imaging of D2 dopamine receptors of patients with Parkinson's disease using single photon emission computed tomography and iodobenzamide I 123.
    Laulumaa V; Kuikka JT; Soininen H; Bergström K; Länsimies E; Riekkinen P
    Arch Neurol; 1993 May; 50(5):509-12. PubMed ID: 8489408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The differential diagnosis of Parkinson diseases--123I-IBZM-SPECT vs. the apomorphine test].
    Hierholzer J; Cordes M; Schelosky L; Sander B; Böck JC; David I; Horowski R; Poewe W
    Rofo; 1993 Jul; 159(1):86-90. PubMed ID: 8334264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steele-Richardson-Olszewski-syndrome: reduction of dopamine D2 receptor binding relates to the severity of midbrain atrophy in vivo: (123)IBZM SPECT and MRI study.
    Arnold G; Tatsch K; Kraft E; Oertel WH; Schwarz J
    Mov Disord; 2002 May; 17(3):557-62. PubMed ID: 12112207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iodine-123-IBF SPECT evaluation of extrapyramidal diseases.
    Buck A; Westera G; Sutter M; Albani C; Kung HF; vonSchulthess GK
    J Nucl Med; 1995 Jul; 36(7):1196-200. PubMed ID: 7790944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations of striatal dopamine D2 receptors contribute to deteriorated response to L-dopa in Parkinson's disease: a [123I]-IBZM SPET study.
    Pizzolato G; Chierichetti F; Rossato A; Cagnin A; Fabbri M; Dam M; Ferlin G; Battistin L
    J Neural Transm Suppl; 1995; 45():113-22. PubMed ID: 8748616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine D2-receptor imaging with 123I-iodobenzamide SPECT in migraine patients abusing ergotamine: does ergotamine cross the blood brain barrier?
    Verhoeff NP; Visser WH; Ferrari MD; Saxena PR; van Royen EA
    Cephalalgia; 1993 Oct; 13(5):325-9. PubMed ID: 8242725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 123I-iodobenzamide-SPECT in 83 patients with de novo parkinsonism.
    Schwarz J; Tatsch K; Arnold G; Ott M; Trenkwalder C; Kirsch CM; Oertel WH
    Neurology; 1993 Dec; 43(12 Suppl 6):S17-20. PubMed ID: 8264906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thiethylperazine-induced parkinsonism: in vivo demonstration of dopamine D2 receptors blockade.
    Briani C; Cagnin A; Chierichetti F; Tiberio M; Battistin L; Pizzolato G
    Eur J Neurol; 2004 Oct; 11(10):709-10. PubMed ID: 15469457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Striatal dopamine release after prefrontal repetitive transcranial magnetic stimulation in major depression: preliminary results of a dynamic [123I] IBZM SPECT study.
    Pogarell O; Koch W; Pöpperl G; Tatsch K; Jakob F; Zwanzger P; Mulert C; Rupprecht R; Möller HJ; Hegerl U; Padberg F
    J Psychiatr Res; 2006 Jun; 40(4):307-14. PubMed ID: 16259998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo SPECT imaging of CNS D-2 dopamine receptors: initial studies with iodine-123-IBZM in humans.
    Kung HF; Alavi A; Chang W; Kung MP; Keyes JW; Velchik MG; Billings J; Pan S; Noto R; Rausch
    J Nucl Med; 1990 May; 31(5):573-9. PubMed ID: 2140408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine D2 receptor binding before and after treatment of major depression measured by [123I]IBZM SPECT.
    Klimke A; Larisch R; Janz A; Vosberg H; Müller-Gärtner HW; Gaebel W
    Psychiatry Res; 1999 Apr; 90(2):91-101. PubMed ID: 10482381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.